Proceeds from Valour sales to support
veteran organizations across Canada
EDMONTON, AB, March 2,
2023 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:
ACB) (TSX: ACB), the Canadian company opening the world to
cannabis, today announced the launch of Valour, a new cannabis
cultivar designed for veterans, by veterans. Five per cent of
net profits from the sale of Valour products will be used to
support veteran organizations across Canada.
Sold under the MedReleaf brand, Valour, aptly named by Canadian
veterans, was developed alongside the veteran community to embody
their most desired aroma, flavour and appearance traits. An
original cultivar bred by Occo, Aurora's leading science and
genetics business, Valour, is derived from Chemdawg, OG18 and Skunk
genetics and features notes of forest pine, sweet citrus and
pungent gas. A premium indica, Valour contains 20-26% THC and is
available in 5g and 15g dried flower, as well as pre-rolls which
are exclusive to veteran Aurora medical patients.
"We're honoured to support Canadian veterans, and proud that we
were able to work hand-in-hand with the veteran community to
provide a product that best serves their needs and preferences,"
says Andre Jerome, Interim SVP of
Medical Sales at Aurora Cannabis. "We are committed to serving
those who have served our country and are giving back a portion of
the proceeds from the sale of Valour to fund the important work
that veteran-focused organizations do to support their
community."
Proceeds from the sale of Valour, up to $200,000 per year, will be used to contribute
cash and in-kind donations to veteran-focused organizations and
clinics across Canada, including:
Fondation Le Balancier / The Pendulum Foundation, The Post
Traumatic Growth Association, The Valhalla Project and Thunder Ride
Trois-Rivières, among others.
For more information about Valour or to learn more about
becoming an Aurora medical cannabis patient, visit Aurora
Medical.
About Aurora
Aurora is opening the world to cannabis, serving both the
medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis, dedicated to helping people improve their lives.
The Company's adult-use brand portfolio includes Aurora Drift, San
Rafael '71, Daily Special, Whistler, Being and Greybeard, as well
as CBD brands, Reliva and KG7. Medical cannabis brands include
MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co.
Aurora also has a controlling interest in Bevo Farms Ltd.,
North America's leading supplier
of propagated agricultural plants. Driven by science and
innovation, and with a focus on high-quality cannabis products,
Aurora's brands continue to break through as industry leaders in
the medical, performance, wellness and adult recreational markets
wherever they are launched. Learn more at www.auroramj.com and
follow us on Twitter and LinkedIn.
Aurora's common shares trade on the NASDAQ and TSX under the
symbol "ACB".
Forward Looking
Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. Forward-looking statements made in this news
release include, but are not limited to, statements regarding the
launch of new products to market and the use of net proceeds.
These forward-looking statements are only predictions. Forward
looking information or statements contained in this news release
have been developed based on assumptions management considers to be
reasonable. Material factors or assumptions involved in
developing forward-looking statements include, without limitation,
publicly available information from governmental sources as well as
from market research and industry analysis and on assumptions based
on data and knowledge of this industry which the Company believes
to be reasonable. Forward-looking statements are subject to a
variety of risks, uncertainties and other factors that management
believes to be relevant and reasonable in the circumstances could
cause actual events, results, level of activity, performance,
prospects, opportunities or achievements to differ materially from
those projected in the forward-looking statements. These risks
include, but are not limited to, the ability to retain key
personnel, the ability to continue investing in infrastructure to
support growth, the ability to obtain financing on acceptable
terms, the continued quality of our products, customer experience
and retention, the development of third party government and
non-government consumer sales channels, management's
estimates of consumer demand in Canada and in jurisdictions where the Company
exports, expectations of future results and expenses, the risk of
successful integration of acquired business and operations,
management's estimation that SG&A will grow only in proportion
of revenue growth, the ability to expand and maintain distribution
capabilities, the impact of competition, the general impact of
financial market conditions, the yield from cannabis growing
operations, product demand, changes in prices of required
commodities, competition, and the possibility for changes in laws,
rules, and regulations in the industry, epidemics, pandemics or
other public health crises, including the current outbreak of
COVID-19, and other risks, uncertainties and factors set out under
the heading "Risk Factors" in the Company's annual information form
dated September 20, 2022 (the "AIF")
and filed with Canadian securities regulators available on the
Company's issuer profile on SEDAR at www.sedar.com and filed
with and available on the SEC's website at www.sec.gov. The
Company cautions that the list of risks, uncertainties and other
factors described in the AIF is not exhaustive and other factors
could also adversely affect its results. Readers are urged to
consider the risks, uncertainties and assumptions carefully in
evaluating the forward-looking statements and are cautioned not to
place undue reliance on such information. The Company is under no
obligation, and expressly disclaims any intention or obligation, to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
expressly required by applicable securities law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/aurora-launches-new-medical-flower-product-valour---designed-for-veterans-by-veterans-301760353.html
SOURCE Aurora Cannabis Inc.